论文部分内容阅读
目的研究分析丹奥治疗急性进展性脑梗死的临床疗效。方法将116例急性脑梗死的患者,随机分为丹奥治疗组60例,对照组56例,进行临床及实验室指标观察并进行比较。结果治疗组进展发生率13.33%,总有效率83.33%,对照组进展率25%,总有效率62.14%,两组比较差异有统计学意义(P<0.01)。神经功能缺损评分减少程度明显优于对照组。丹奥作用迅速,抑制血小板聚集,降低血粘度,促进血栓溶解,促进病情好转和恢复。结论丹奥治疗急性进展性脑梗死,疗效确切,安全可靠,无明显不良反应,值得在临床上推广应用。
Objective To study the clinical efficacy of Danio in the treatment of acute progressive cerebral infarction. Methods A total of 116 patients with acute cerebral infarction were randomly divided into Danao treatment group (60 cases) and control group (56 cases). The clinical and laboratory indexes were observed and compared. Results The progress rate of the treatment group was 13.33%, the total effective rate was 83.33%, the control group was 25%, the total effective rate was 62.14%. The difference between the two groups was statistically significant (P <0.01). Neurological impairment score was significantly lower than the control group. Danio rapid action, inhibition of platelet aggregation, reduce blood viscosity, promote thrombolysis, improve the condition and recovery. Conclusion Danio treatment of acute progressive cerebral infarction, curative effect is exact, safe and reliable, no obvious adverse reactions, it is worth in the clinical application.